Both in Surgical Instruments
AtriCure vs Pulse Biosciences, Inc Common Stock (DE)
Over the past year ATRC returned +66.5% and PLSE returned +185.9%; their daily moves had a correlation of 0.15.
ATRC +66.5% PLSE +185.9%Growth of $1, one year, split-adjusted
| Metric | ATRC | PLSE |
|---|---|---|
| Price | $58.05 | $50.89 |
| Market cap | $2.95B | $3.63B |
| Today | −0.62% | −2.73% |
| 1 month | +19.6% | +7.0% |
| 6 months | +105.4% | +159.2% |
| Year to date | +46.7% | +270.6% |
| 1 year | +64.9% | +186.4% |
| Revenue growth (YoY) | +12.8% | — |
| Gross margin | 77.2% | 37.1% |
| Net margin | 5.8% | −5681.3% |
| P/E (TTM) | 279.8× | — |
| Price / sales | 5.2× | 3,063.0× |
| Net cash | $106.8M | $101.6M |
| Dividend yield | — | — |
| Volatility (60d) | 39.5% | 65.3% |
| Short % of float | 8.8% | 17.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).